Human visceral and subcutaneous adipose stem and progenitor cells retain depot-specific adipogenic properties during obesity

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Human visceral and subcutaneous adipose stem and progenitor cells retain depot-specific adipogenic properties during obesity. / Mathur, Neha; Severinsen, Mai C.K.; Jensen, Mette E.; Naver, Lars; Schrölkamp, Maren; Laye, Matthew J.; Watt, Matthew J.; Nielsen, Søren; Krogh-Madsen, Rikke; Pedersen, Bente Klarlund; Scheele, Camilla.

In: Frontiers in Cell and Developmental Biology, Vol. 10, 983899, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Mathur, N, Severinsen, MCK, Jensen, ME, Naver, L, Schrölkamp, M, Laye, MJ, Watt, MJ, Nielsen, S, Krogh-Madsen, R, Pedersen, BK & Scheele, C 2022, 'Human visceral and subcutaneous adipose stem and progenitor cells retain depot-specific adipogenic properties during obesity', Frontiers in Cell and Developmental Biology, vol. 10, 983899. https://doi.org/10.3389/fcell.2022.983899

APA

Mathur, N., Severinsen, M. C. K., Jensen, M. E., Naver, L., Schrölkamp, M., Laye, M. J., Watt, M. J., Nielsen, S., Krogh-Madsen, R., Pedersen, B. K., & Scheele, C. (2022). Human visceral and subcutaneous adipose stem and progenitor cells retain depot-specific adipogenic properties during obesity. Frontiers in Cell and Developmental Biology, 10, [983899]. https://doi.org/10.3389/fcell.2022.983899

Vancouver

Mathur N, Severinsen MCK, Jensen ME, Naver L, Schrölkamp M, Laye MJ et al. Human visceral and subcutaneous adipose stem and progenitor cells retain depot-specific adipogenic properties during obesity. Frontiers in Cell and Developmental Biology. 2022;10. 983899. https://doi.org/10.3389/fcell.2022.983899

Author

Mathur, Neha ; Severinsen, Mai C.K. ; Jensen, Mette E. ; Naver, Lars ; Schrölkamp, Maren ; Laye, Matthew J. ; Watt, Matthew J. ; Nielsen, Søren ; Krogh-Madsen, Rikke ; Pedersen, Bente Klarlund ; Scheele, Camilla. / Human visceral and subcutaneous adipose stem and progenitor cells retain depot-specific adipogenic properties during obesity. In: Frontiers in Cell and Developmental Biology. 2022 ; Vol. 10.

Bibtex

@article{069786422e43487299c50ddc66de1084,
title = "Human visceral and subcutaneous adipose stem and progenitor cells retain depot-specific adipogenic properties during obesity",
abstract = "Abdominal obesity associates with cardiometabolic disease and an accumulation of lipids in the visceral adipose depot, whereas lipid accumulation in the subcutaneous depot is more benign. We aimed to further investigate whether the adipogenic properties where cell-intrinsic, or dependent on a depot-specific or obesity-produced microenvironment. We obtained visceral and subcutaneous biopsies from non-obese women (n = 14) or women living with morbid obesity (n = 14) and isolated adipose stem and progenitor cells (ASPCs) from the stromal vascular fraction of non-obese (n = 13) and obese (n = 13). Following in vitro differentiation into mature adipocytes, we observed a contrasting pattern with a lower gene expression of adipogenic markers and a higher gene expression of immunogenic markers in the visceral compared to the subcutaneous adipocytes. We identified the immunogenic factor BST2 as a marker for visceral ASPCs. The effect of obesity and insulin resistance on adipogenic and immunogenic markers in the in vitro differentiated cells was minor. In contrast, differentiation with exogenous Tumor necrosis factor resulted in increased immunogenic signatures, including increased expression of BST2, and decreased adipogenic signatures in cells from both depots. Our data, from 26 women, underscore the intrinsic differences between human visceral and subcutaneous adipose stem and progenitor cells, suggest that dysregulation of adipocytes in obesity mainly occurs at a post-progenitor stage, and highlight an inflammatory microenvironment as a major constraint of human adipogenesis.",
keywords = "adipogenesis, human adipocytes, immunogenic adipocytes, obesity, subcutaneous adipocytes, visceral adipocytes",
author = "Neha Mathur and Severinsen, {Mai C.K.} and Jensen, {Mette E.} and Lars Naver and Maren Schr{\"o}lkamp and Laye, {Matthew J.} and Watt, {Matthew J.} and S{\o}ren Nielsen and Rikke Krogh-Madsen and Pedersen, {Bente Klarlund} and Camilla Scheele",
note = "Publisher Copyright: Copyright {\textcopyright} 2022 Mathur, Severinsen, Jensen, Naver, Schr{\"o}lkamp, Laye, Watt, Nielsen, Krogh-Madsen, Pedersen and Scheele.",
year = "2022",
doi = "10.3389/fcell.2022.983899",
language = "English",
volume = "10",
journal = "Frontiers in Cell and Developmental Biology",
issn = "2296-634X",
publisher = "Frontiers Media",

}

RIS

TY - JOUR

T1 - Human visceral and subcutaneous adipose stem and progenitor cells retain depot-specific adipogenic properties during obesity

AU - Mathur, Neha

AU - Severinsen, Mai C.K.

AU - Jensen, Mette E.

AU - Naver, Lars

AU - Schrölkamp, Maren

AU - Laye, Matthew J.

AU - Watt, Matthew J.

AU - Nielsen, Søren

AU - Krogh-Madsen, Rikke

AU - Pedersen, Bente Klarlund

AU - Scheele, Camilla

N1 - Publisher Copyright: Copyright © 2022 Mathur, Severinsen, Jensen, Naver, Schrölkamp, Laye, Watt, Nielsen, Krogh-Madsen, Pedersen and Scheele.

PY - 2022

Y1 - 2022

N2 - Abdominal obesity associates with cardiometabolic disease and an accumulation of lipids in the visceral adipose depot, whereas lipid accumulation in the subcutaneous depot is more benign. We aimed to further investigate whether the adipogenic properties where cell-intrinsic, or dependent on a depot-specific or obesity-produced microenvironment. We obtained visceral and subcutaneous biopsies from non-obese women (n = 14) or women living with morbid obesity (n = 14) and isolated adipose stem and progenitor cells (ASPCs) from the stromal vascular fraction of non-obese (n = 13) and obese (n = 13). Following in vitro differentiation into mature adipocytes, we observed a contrasting pattern with a lower gene expression of adipogenic markers and a higher gene expression of immunogenic markers in the visceral compared to the subcutaneous adipocytes. We identified the immunogenic factor BST2 as a marker for visceral ASPCs. The effect of obesity and insulin resistance on adipogenic and immunogenic markers in the in vitro differentiated cells was minor. In contrast, differentiation with exogenous Tumor necrosis factor resulted in increased immunogenic signatures, including increased expression of BST2, and decreased adipogenic signatures in cells from both depots. Our data, from 26 women, underscore the intrinsic differences between human visceral and subcutaneous adipose stem and progenitor cells, suggest that dysregulation of adipocytes in obesity mainly occurs at a post-progenitor stage, and highlight an inflammatory microenvironment as a major constraint of human adipogenesis.

AB - Abdominal obesity associates with cardiometabolic disease and an accumulation of lipids in the visceral adipose depot, whereas lipid accumulation in the subcutaneous depot is more benign. We aimed to further investigate whether the adipogenic properties where cell-intrinsic, or dependent on a depot-specific or obesity-produced microenvironment. We obtained visceral and subcutaneous biopsies from non-obese women (n = 14) or women living with morbid obesity (n = 14) and isolated adipose stem and progenitor cells (ASPCs) from the stromal vascular fraction of non-obese (n = 13) and obese (n = 13). Following in vitro differentiation into mature adipocytes, we observed a contrasting pattern with a lower gene expression of adipogenic markers and a higher gene expression of immunogenic markers in the visceral compared to the subcutaneous adipocytes. We identified the immunogenic factor BST2 as a marker for visceral ASPCs. The effect of obesity and insulin resistance on adipogenic and immunogenic markers in the in vitro differentiated cells was minor. In contrast, differentiation with exogenous Tumor necrosis factor resulted in increased immunogenic signatures, including increased expression of BST2, and decreased adipogenic signatures in cells from both depots. Our data, from 26 women, underscore the intrinsic differences between human visceral and subcutaneous adipose stem and progenitor cells, suggest that dysregulation of adipocytes in obesity mainly occurs at a post-progenitor stage, and highlight an inflammatory microenvironment as a major constraint of human adipogenesis.

KW - adipogenesis

KW - human adipocytes

KW - immunogenic adipocytes

KW - obesity

KW - subcutaneous adipocytes

KW - visceral adipocytes

U2 - 10.3389/fcell.2022.983899

DO - 10.3389/fcell.2022.983899

M3 - Journal article

C2 - 36340033

AN - SCOPUS:85140988751

VL - 10

JO - Frontiers in Cell and Developmental Biology

JF - Frontiers in Cell and Developmental Biology

SN - 2296-634X

M1 - 983899

ER -

ID: 325672460